How to Enter the U.S. Market: A Comprehensive Guide for MedTech Sales Teams

A Practical Guide for MedTech Sales Teams

The United States represents the largest healthcare market in the world — over $4.9 trillion in annual spending according to the Centers for Medicare and Medicaid Services.

But entering the U.S. MedTech ecosystem is far from simple.

Companies must navigate FDA regulatory pathways, hospital procurement systems, reimbursement structures, and complex distribution networks before their product can reach physicians and patients.

This guide explains how successful MedTech companies approach U.S. market entry and what commercial teams need to prepare for before launching.

📥 Download the Guide

Includes:

• Practical overview of FDA approval pathways
• Key U.S. healthcare stakeholders
• Proven MedTech distribution models
• Strategies to accelerate product adoption
• A ready-to-use FDA Market Entry Checklist

What You’ll Learn Inside the Guide

Entering the U.S. market requires more than regulatory approval. Commercial success depends on understanding how healthcare systems, hospitals, and physicians actually adopt new technologies.

Inside the guide you’ll learn:

✅ The 4 key steps MedTech companies must take before launching in the U.S.

✅ How the FDA approval process works and what commercial teams should know

✅ How MedTech companies sell into U.S. hospitals and healthcare systems

✅ The three most common distribution strategies used by MedTech companies

✅ How clinical data and KOL engagement influence adoption

✅ A practical FDA Medical Device Market Entry Checklist

Get a glimpse of the insights inside our MedTech U.S. Market Entry Guide — including regulatory pathways, hospital sales strategies, and a practical FDA market entry checklist.

Who This Guide Is For

This guide is designed for:

• MedTech founders
• Commercial leaders
• Sales teams expanding internationally
• Market access and strategy teams
• Companies preparing for U.S. expansion

If your company is planning to enter the U.S. healthcare market, this guide provides a clear overview of the commercial and regulatory landscape.

Why U.S. Market Entry Is So Challenging

Many MedTech companies underestimate the complexity of the U.S. healthcare ecosystem.

Medical devices entering the U.S. market must meet regulatory requirements set by the U.S. Food and Drug Administration.

Beyond FDA approval, companies must also navigate:

• Hospital procurement committees
• Physician adoption barriers
• Reimbursement pathways
• Regional distribution models
• Clinical evidence expectations

Understanding these dynamics early can significantly reduce time-to-market and improve adoption success.

What’s Inside the Guide

The guide provides a structured overview of the U.S. MedTech market entry process, including:

1. Market Entry Strategy

How to define your U.S. positioning and prioritize target segments.

2. FDA Regulatory Pathways

Overview of approval routes and how they impact commercialization timelines.

3. Hospital Sales Strategy

How MedTech companies engage physicians, procurement committees, and healthcare administrators.

4. Distribution & Go-To-Market Models

Direct sales, distributor partnerships, and hybrid models.

5. Clinical Evidence & Adoption

How clinical data and key opinion leaders drive product adoption.

MedTech U.S. Market Entry Checklist

Before launching in the United States, MedTech companies should ensure:

1. FDA regulatory pathway identified
2. Clinical evidence strategy defined
3. Hospital decision-makers mapped
4. Distribution model selected
5. Key opinion leaders engaged

Bonus: FDA Medical Device Market Entry Checklist

The guide also includes a practical checklist covering the essential steps companies must prepare before launching a medical device in the U.S.

This checklist helps teams ensure they are ready across:

• Regulatory preparation
• Commercial strategy
• Clinical evidence
• Distribution planning

📥 Download the Full Guide

Ready to accelerate your U.S. expansion?

Learn how MedTech companies successfully navigate FDA approval, build hospital sales channels, and establish a strong presence in the U.S. healthcare market.